General Information of This Drug (ID: DM4G60V)

Drug Name
AC265347   DM4G60V
Synonyms AC-265347; AC 265347
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

5 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
AC265347 + Diltiazem DC7JKZG Diltiazem DD2 (Cell Line: DD2) [2]
AC265347 + Chloroquine DC1KIZ3 Chloroquine DD2 (Cell Line: DD2) [2]
AC265347 + Piperaquine DCKVV8I Piperaquine DD2 (Cell Line: DD2) [2]
AC265347 + Diltiazem DCM53W5 Diltiazem Hepatoblastoma (Cell Line: HB3) [3]
Artemisinin + AC265347 DCS6XOU Artemisinin DD2 (Cell Line: DD2) [2]
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3947).
2 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
3 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.